CYRAMZA

Google image searchProduct monograph

Active ingredient

ramucirumab, 10 MG/ML

DIN: 02443805

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE USE VIALS

Schedule: Prescription / Schedule D

Company: ELI LILLY CANADA INC

Date: 10-SEP-2015

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
• L01FG — VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors (ATC, ATC/DDD)
• L01FG02 — RAMUCIRUMAB (ATC/DDD)

Pharmaceutical standard: USP

External Links for Cyramza

Search on Google

• Cyramza side effects
• Cyramza dosage
• ramucirumab side effects
• ramucirumab dosage

Eli Lilly Canada Inc

Go to Eli Lilly website to see drug product details. Sometimes you can find cyramza photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.